VA
INSM icon

Vident Advisory’s Insmed INSM Stock Holding History

Vident Advisory’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
9,856
+48
+0.5% +$5.81K 0.01% 944
2026
Q1 		$1.6M Buy
9,808
+4,794
+96% +$737K 0.01% 691
2025
Q4 		$873K Sell
5,014
-544
-10% -$99.3K 0.01% 874
2025
Q3 		$800K Sell
5,558
-121
-2% -$14.8K 0.01% 938
2025
Q2 		$572K Sell
5,679
-1,176
-17% -$89.9K 0.01% 970
2025
Q1 		$523K Buy
6,855
+1,918
+39% +$147K 0.01% 1008
2024
Q4 		$341K Buy
4,937
+1,312
+36% +$94.5K 0.01% 1123
2024
Q3 		$265K Buy
+3,625
New +$268K 0.01% 1183

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vident Advisory's INSM Position: Q2 2026 in Review

Vident Advisory increased its Insmed (INSM) stake by 0.49% in Q2 2026, buying an estimated $5.81K and bringing the position to 9,856 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #944.

Vident Advisory first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.6M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Vident Advisory held 9,856 shares of Insmed worth $1.05M as of Q2 2026.
  • Vident Advisory bought 48 Insmed shares in Q2 2026, an estimated $5.81K.
  • Insmed made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #944 holding.
  • Vident Advisory first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
  • Vident Advisory's Insmed position peaked at $1.6M in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.